Steidl S - Search Results

1

MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.

Stitz J, Steidl S, Merget-Millitzer H, König R, Müller P, Nocken F, Engelstädter M, Bobkova M, Schmitt I, Kurth R, Buchholz CJ, Cichutek K. Stitz J, et al. Among authors: steidl s. Virology. 2000 Feb 15;267(2):229-36. doi: 10.1006/viro.1999.0121. Virology. 2000. PMID: 10662618 Free article.

2

Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange.

Steidl S, Stitz J, Schmitt I, König R, Flory E, Schweizer M, Cichutek K. Steidl S, et al. Virology. 2002 Sep 1;300(2):205-16. doi: 10.1006/viro.2001.1565. Virology. 2002. PMID: 12350351 Free article.

3

Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.

König RR, Flory E, Steidl S, Neumann J, Coulibaly C, Holznagel E, Holzammer S, Norley S, Cichutek K. König RR, et al. Among authors: steidl s. J Virol. 2002 Nov;76(21):10627-36. doi: 10.1128/jvi.76.21.10627-10636.2002. J Virol. 2002. PMID: 12368305 Free PMC article.

4

Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.

Mühlebach MD, Schmitt I, Steidl S, Stitz J, Schweizer M, Blankenstein T, Cichutek K, Uckert W. Mühlebach MD, et al. Among authors: steidl s. J Mol Med (Berl). 2003 Dec;81(12):801-10. doi: 10.1007/s00109-003-0491-2. Epub 2003 Oct 24. J Mol Med (Berl). 2003. PMID: 14576928

5

Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.

Steidl S, Schüle S, Mühlebach MD, Stitz J, Boller K, Cichutek K, Schweizer M. Steidl S, et al. J Gen Virol. 2004 Mar;85(Pt 3):665-678. doi: 10.1099/vir.0.19479-0. J Gen Virol. 2004. PMID: 14993652

6

Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.

Schüle S, Steidl S, Panitz S, Coulibaly C, Kalinke U, Cichutek K, Schweizer M. Schüle S, et al. Among authors: steidl s. Virology. 2006 Jul 20;351(1):237-47. doi: 10.1016/j.virol.2006.03.034. Epub 2006 May 2. Virology. 2006. PMID: 16650881 Free article.

7

Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.

Engelstädter M, Buchholz CJ, Bobkova M, Steidl S, Merget-Millitzer H, Willemsen RA, Stitz J, Cichutek K. Engelstädter M, et al. Among authors: steidl s. Gene Ther. 2001 Aug;8(15):1202-6. doi: 10.1038/sj.gt.3301500. Gene Ther. 2001. PMID: 11509952

8

A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.

Stitz J, Mühlebach MD, Blömer U, Scherr M, Selbert M, Wehner P, Steidl S, Schmitt I, König R, Schweizer M, Cichutek K. Stitz J, et al. Among authors: steidl s. Virology. 2001 Dec 20;291(2):191-7. doi: 10.1006/viro.2001.1183. Virology. 2001. PMID: 11878888 Free article.

9

Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated anti-tumor efficacy of tafasitamab.

Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, Altmeyer S, Bittenbring JT, Augsberger C, Ilieva-Babinsky K, Haskamp S, Beier F, Lischer C, Vera J, Lührmann A, Bertz S, Völkl S, Jacobs B, Steidl S, Mackensen A, Bruns H. Biedermann A, et al. Among authors: steidl s. Haematologica. 2024 Jun 27. doi: 10.3324/haematol.2023.284795. Online ahead of print. Haematologica. 2024. PMID: 38934068 Free article.

10

CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.

Sakemura RL, Manriquez Roman C, Horvei P, Siegler EL, Girsch JH, Sirpilla OL, Stewart CM, Yun K, Can I, Ogbodo EJ, Adada MM, Bezerra ED, Kankeu Fonkoua LA, Hefazi M, Ruff MW, Kimball BL, Mai LK, Huynh TN, Nevala WK, Ilieva K, Augsberger C, Patra-Kneuer M, Schanzer J, Endell J, Heitmüller C, Steidl S, Parikh SA, Ding W, Kay NE, Nowakowski GS, Kenderian SS. Sakemura RL, et al. Among authors: steidl s. Blood. 2024 Jan 18;143(3):258-271. doi: 10.1182/blood.2022018905. Blood. 2024. PMID: 37879074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page